Arca
Skip to content
Tools
Tools

Fibered Platinum Coil, .035 Type

Device, Vascular, For Promoting Embolization. 510(k) K955293, from Target Therapeutics (Freemont, CA). Product code KRD, class 2.

As of Nov 18, 2026, K955293 is an FDA 510(k) held by Target Therapeutics, substantially equivalent on Feb 6, 1996 after 82 days, with 2 recalls tied to it in FDA's recall database.

  • Review time: 82 days
  • Recalls: 2
  • Cited as a predicate by: 6 devices

Cited as a predicate

6 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K955293, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Jun 23, 2003Z-1034-03, Z-1033-03Product 's Outer box label may not match pouch label: a 4mm x 30 mm coil may be labeled as a 9 mm x 60 mm or vice versaTerminated

Other KRD clearances

The newest 510(k)s for the same product code; their median review was 70 days; see every KRD device

Record

Type
Traditional
Received
Nov 16, 1995
Review panel
Cardiovascular
Regulation
21 CFR 870.3300

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.